Orthofix International Announces International Launch of Galaxy Fixation

February 8, 2012

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today the international launch of Galaxy Fixation at the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting this week in San Francisco, CA. This new external fixation system is designed for use in temporary and definitive, complex orthopedic trauma applications, where rapid stabilization and fixation is essential.

"Orthofix has designed yet another innovative external fixation system that brings simplicity and stability to a new level," said Robert Vaters, President and Chief Executive Officer. "The introduction of Galaxy Fixation represents Orthofix's commitment to maintaining its leadership in external fixation in international markets. We are excited to offer this next-generation, modular system that provides multi-functional, fracture management capabilities in both upper and lower extremity applications for our surgeon customers outside the U.S."

Galaxy Fixation incorporates a streamlined combination of clamps with both pin-to-bar and bar-to-bar coupling capabilities that provide a complete range of anatomical applications and reduces inventory. It also includes specific units for the elbow and shoulder. While the rigidity and stability allows for use in definitive fixation, the design also addresses the need for rapid stabilization needed for temporary fixation in large trauma centers.

About Orthofix:

Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, including BREG, Inc., and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, Texas Scottish Rite Hospital for Children, and the Cleveland Clinical Foundation. For more information about Orthofix, please visit www.orthofix.com.

Orthofix International N.V.
Mark Quick, 214-937-2924
Director of Investor Relations
and Business Development

Source: Orthofix International N.V.

News Provided by Acquire Media